Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16100946 | 0.81 | SMN1; SMN2 (0.47) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL9760116 | 0.76 | TSHR (0.45) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL8002486 | 0.71 | TSHR (0.46) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL5177766 | 0.70 | TSHR (0.45) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL13532301 | 0.70 | TSHR (0.61) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL16661604 | 0.70 | TSHR (0.61) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL2066081 | 0.70 | TSHR (0.61) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL18371651 | 0.70 | TSHR (0.61) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL2006386 | 0.70 | TSHR (0.61) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL642391 | 0.68 | TSHR (0.53) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016057288-A1 | QUATERNARY ORGANOSILICON SURFACTANTS, METHODS OF MAKING SAME AND APPLICATIONS CONTAINING THE SAME | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-04-14 | — | — | WO | disclosed |
| US-20160100573-A1 | QUATERNARY ORGANOSILICON SURFACTANTS, METHODS OF MAKING SAME AND APPLICATIONS CONTAINING THE SAME | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160100573-A1 | QUATERNARY ORGANOSILICON SURFACTANTS, METHODS OF MAKING SAME AND APPLICATIONS CONTAINING THE SAME | OXSR1, C1R, AOC1 | SMN1; SMN2 1454/4885TSHR 466/4885ALDH1A1 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.